Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Diversified Financials
Create a narrative
Paysign
NasdaqCM:PAYS Community
1
Narratives
written by author
0
Comments
on narratives written by author
15
Fair Values set
on narratives written by author
Create a narrative
Paysign
Popular
Undervalued
Overvalued
Paysign
WA
Analyst Price Target
Consensus Narrative from 5 Analysts
Patient Affordability Expansion May Improve Future Prospects But Operational Risks Could Impact Profits
Key Takeaways Rapid growth in patient affordability programs and onboarding major pharmaceutical accounts likely to significantly boost revenue. Strategic expansion and investments in plasma centers and IT aim to improve long-term revenue and efficiency.
View narrative
US$6.65
FV
55.8% undervalued
intrinsic discount
11.45%
Revenue growth p.a.
Set as Fair Value
0
users have liked this narrative
0
users have commented on this narrative
5
users have followed this narrative
24 days ago
author updated this narrative
Your Valuation for
PAYS
Paysign
Your Fair Value
US$
Current Price
US$2.94
12.5% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-7m
96m
2015
2018
2021
2024
2025
2027
2030
Revenue US$95.6m
Earnings US$13.7m
Advanced
Set as Fair Value